Todd Franklin Watanabe Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Todd Franklin Watanabe is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 838,430 shares of ARQT, which is worth approximately $12.6 Million. The most recent transaction as insider was on Jul 08, 2022, when has been sold 7,087 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $11,906. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 838K

0.93% 3M change

67.01% 12M change

Total Value Held $12.6 Million

Todd Franklin Watanabe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 08 2022	BUY Exercise of conversion of derivative security	$11,906 $1.68 p/Share	7,087 Added 1.06%	658,958 Common Stock
Jul 06 2022	SELL Open market or private sale	$22,070 $22.07 p/Share	1,000 Reduced 0.15%	658,284 Common Stock
Jun 23 2022	SELL Bona fide gift	-	268,964 Reduced 41.26%	382,907 Common Stock
Jun 06 2022	SELL Open market or private sale	$21,060 $21.06 p/Share	1,000 Reduced 0.15%	659,284 Common Stock
May 05 2022	SELL Open market or private sale	$21,760 $21.76 p/Share	1,000 Reduced 0.15%	658,667 Common Stock
Apr 05 2022	SELL Open market or private sale	$21,430 $21.43 p/Share	1,000 Reduced 0.15%	659,667 Common Stock
Mar 09 2022	SELL Open market or private sale	$5,100 $17.0 p/Share	300 Reduced 0.05%	660,667 Common Stock
Mar 07 2022	SELL Open market or private sale	$12,921 $16.78 p/Share	770 Reduced 0.12%	660,967 Common Stock
Mar 07 2022	BUY Exercise of conversion of derivative security	$1,176 $1.68 p/Share	700 Added 0.11%	661,667 Common Stock
Mar 04 2022	SELL Open market or private sale	$41,965 $16.86 p/Share	2,489 Reduced 0.38%	661,037 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	70,900 Added 9.65%	663,526 Common Stock
Mar 01 2022	SELL Open market or private sale	$38,216 $17.75 p/Share	2,153 Reduced 0.36%	592,626 Common Stock
Feb 09 2022	SELL Open market or private sale	$17,000 $17.0 p/Share	1,000 Reduced 0.17%	594,779 Common Stock
Feb 09 2022	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Jan 05 2022	SELL Open market or private sale	$21,860 $21.86 p/Share	1,000 Reduced 0.17%	594,779 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Dec 08 2021	SELL Open market or private sale	$17,000 $17.0 p/Share	1,000 Reduced 0.17%	594,779 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Nov 05 2021	SELL Open market or private sale	$21,500 $21.5 p/Share	1,000 Reduced 0.17%	594,779 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Oct 05 2021	SELL Open market or private sale	$62,300 $24.92 p/Share	2,500 Reduced 0.42%	594,779 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$4,200 $1.68 p/Share	2,500 Added 0.42%	597,279 Common Stock
Oct 01 2021	SELL Open market or private sale	$37,515 $25.01 p/Share	1,500 Reduced 0.25%	594,779 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$2,520 $1.68 p/Share	1,500 Added 0.25%	596,279 Common Stock
Sep 07 2021	SELL Open market or private sale	$21,140 $21.14 p/Share	1,000 Reduced 0.17%	594,779 Common Stock

TFW

Todd Franklin Watanabe

Director

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account